首页> 美国卫生研究院文献>Journal of Nuclear Medicine >Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct
【2h】

Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct

机译:可视化的端粒酶逆转录酶(hTERT)启动子活性使用三峰融合报告人构建。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our goal was to noninvasively measure chemotherapy-induced changes in the expression of critical tumor growth genes. To achieve this goal, we used radionuclide and optical methods to measure changes in human telomerase reverse transcriptase (hTERT) gene expression in tumor cells before and after 5-fluorouracil treatment.MethodsA fusion reporter construct, containing humanized Renilla luciferase (hrl, for bioluminescent imaging), monomeric red fluorescence protein 1 (mrfp1, for fluorescent imaging), and a truncated thymidine kinase (ttk, for imaging of radiolabeled acycloguanosines), was placed under the control of hTERT promoter fragments. These constructs were introduced into tumor cell lines with and without hTERT expression. Transfected cells were treated with 5-fluorouracil, a chemotherapeutic that decreases hTERT gene expression, and treatment-induced changes in hTERT promoter activity were imaged.
机译:我们的目标是非侵入性地测量化学疗法诱导的关键肿瘤生长基因表达的变化。为了实现这一目标,我们使用了放射性核素和光学方法来测量5-氟尿嘧啶治疗前后肿瘤细胞中人类端粒酶逆转录酶(hTERT)基因表达的变化。方法包含人源化海肾荧光素酶(hrl)的融合报告基因构建物,用于生物发光成像),单体红色荧光蛋白1(mrfp1,用于荧光成像)和截短的胸苷激酶(ttk,用于放射性标记的无环鸟苷成像)置于hTERT启动子片段的控制下。将这些构建体引入具有和不具有hTERT表达的肿瘤细胞系中。用5-氟尿嘧啶(一种降低hTERT基因表达的化学治疗剂)处理转染的细胞,并对hTERT启动子活性的治疗诱导变化进行成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号